| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 3.43B | 3.39B | 3.33B | 3.19B | 2.79B |
| Gross Profit | 583.70M | 553.90M | 1.91B | 484.90M | 445.40M |
| EBITDA | 786.60M | 725.30M | 678.00M | 677.90M | 626.90M |
| Net Income | 343.50M | 345.40M | 297.40M | 288.80M | 288.10M |
Balance Sheet | |||||
| Total Assets | 3.76B | 3.60B | 3.54B | 3.66B | 3.25B |
| Cash, Cash Equivalents and Short-Term Investments | 329.20M | 343.00M | 299.30M | 321.60M | 265.90M |
| Total Debt | 1.65B | 1.14B | 1.22B | 1.38B | 1.29B |
| Total Liabilities | 2.63B | 2.15B | 2.18B | 2.34B | 2.14B |
| Stockholders Equity | 1.08B | 1.40B | 1.32B | 1.28B | 1.08B |
Cash Flow | |||||
| Free Cash Flow | 395.60M | 462.10M | 418.10M | 445.60M | 454.60M |
| Operating Cash Flow | 540.10M | 597.10M | 535.00M | 562.10M | 551.70M |
| Investing Cash Flow | -323.40M | -142.20M | -145.10M | -175.50M | -587.90M |
| Financing Cash Flow | -213.20M | -402.40M | -376.20M | -334.90M | 122.80M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | £2.90B | 19.41 | 16.69% | 1.27% | 0.84% | -62.73% | |
76 Outperform | £2.18B | 13.52 | 20.41% | 2.58% | 11.42% | -17.18% | |
65 Neutral | £5.74B | 21.21 | 31.07% | 3.44% | 1.14% | 17.74% | |
65 Neutral | £12.27B | 31.67 | 6.51% | 1.68% | -1.58% | -34.64% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
54 Neutral | £327.41M | 275.23 | 0.58% | 2.31% | 6.90% | 145.00% | |
41 Neutral | £328.67M | -2.81 | -142.88% | ― | -4.87% | ― |